Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Ras Gene02:38

The Ras Gene

6.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

4.3K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.3K
Abnormal Proliferation02:23

Abnormal Proliferation

4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Rab Proteins01:14

Rab Proteins

4.2K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.2K
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

2.9K
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent p.H119Y variant in MAP2K1 expands the phenotypic spectrum of MAP2K1 -related RASopathy.

American journal of medical genetics. Part A·2024
Same author

Translating multiscale research in rare disease.

Disease models & mechanisms·2024
Same author

RASopathies - what they reveal about RAS/MAPK signaling in skeletal muscle development.

Disease models & mechanisms·2024
Same author

The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy.

American journal of medical genetics. Part A·2023
Same author

Obstetrical and neonatal outcomes of cardio-facio-cutaneous syndrome: Prenatal consequences of Ras/MAPK dysregulation.

American journal of medical genetics. Part A·2022
Same author

The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery.

American journal of medical genetics. Part A·2022
Same journal

Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells.

Disease models & mechanisms·2026
Same journal

Mesoscale maladaptation in disease organoids.

Disease models & mechanisms·2026
Same journal

A modeller's guide for biomedical discovery.

Disease models & mechanisms·2026
Same journal

An antioxidant therapy elicits distinct transcriptome responses in 22q11-deleted upper layer cortical projection neurons.

Disease models & mechanisms·2026
Same journal

Co-mutations of CTNNB1 and PTEN drive aggressive tumor progression in endometrial cancer.

Disease models & mechanisms·2026
Same journal

A Drosophila tumor model identifies a conserved Upd-JAK/STAT-Akh signaling axis associated with metabolic changes in cancer cachexia.

Disease models & mechanisms·2026
See all related articles

Related Experiment Video

Updated: Oct 5, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.1K

Defining RASopathy.

Katherine A Rauen1,2

  • 1Department of Pediatrics, Division of Genomic Medicine, University of California Davis, Sacramento, CA 95817, USA.

Disease Models & Mechanisms
|February 1, 2022
PubMed
Summary
This summary is machine-generated.

RASopathies are genetic syndromes arising from RAS/MAPK pathway variants. Understanding these complex conditions is key, as they may be treatable with pathway modulators.

More Related Videos

A Simple Protocol for Mapping the Plant Root System Architecture Traits
11:09

A Simple Protocol for Mapping the Plant Root System Architecture Traits

Published on: February 10, 2023

3.1K
Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
03:10

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid

Published on: November 1, 2024

3.0K

Related Experiment Videos

Last Updated: Oct 5, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.1K
A Simple Protocol for Mapping the Plant Root System Architecture Traits
11:09

A Simple Protocol for Mapping the Plant Root System Architecture Traits

Published on: February 10, 2023

3.1K
Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
03:10

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid

Published on: November 1, 2024

3.0K

Area of Science:

  • Medical Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • RASopathies are a group of genetic syndromes characterized by overlapping clinical features.
  • These syndromes stem from germline pathogenic variants affecting the RAS/mitogen-activated protein kinase (RAS/MAPK) signaling pathway.
  • The complexity of the RAS/MAPK pathway, including its numerous components, interactions, and phenotypic variability, necessitates a clear definition.

Purpose of the Study:

  • To define the key principles for identifying and classifying RASopathy syndromes.
  • To emphasize the underlying molecular mechanisms and clinical manifestations of RASopathies.
  • To highlight the potential therapeutic implications of understanding RAS/MAPK pathway dysregulation.

Main Methods:

  • Review and synthesis of existing literature on RASopathies and the RAS/MAPK pathway.
  • Analysis of the genetic basis and pathogenetic mechanisms underlying these syndromes.
  • Consideration of the phenotypic spectrum and clinical features associated with RAS/MAPK pathway variants.

Main Results:

  • A RASopathy is defined as a clinical syndrome with shared phenotypic features caused by germline variants in the RAS/MAPK pathway.
  • Multiple pathogenetic mechanisms converge to cause RAS/MAPK pathway activation or dysregulation in RASopathies.
  • Dysfunctional RAS/MAPK pathway activation in RASopathies suggests potential amenability to pathway-modulating therapies.

Conclusions:

  • A clear definition of RASopathies is crucial due to the complexity of the RAS/MAPK pathway.
  • Understanding the shared molecular underpinnings of RASopathies is essential for diagnosis and management.
  • The identification of RAS/MAPK pathway dysregulation opens avenues for targeted therapeutic interventions.